Pancreatic Cancer Research

ResearcherUniversity of OxfordNo recent work listed

Abul Kalam Azad

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4069-6877; OpenAlex author ID A5100688102. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2016: 2 papers · 2017: 2 papers

Papers 4

  1. Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-16-2833↗
  2. PD-L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy. Co-author DOI 10.15252/emmm.201606674↗
  3. Prognostic value, localization and correlation of PD-1/PD-L1, CD8 and FOXP3 with the desmoplastic stroma in pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/oncotarget.10038↗
  4. Prognostic role and correlation of CA9, CD31, CD68 and CD20 with the desmoplastic stroma in pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/oncotarget.12022↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zenobia D’Costa · 4 shared papers, 2016–2017 · strength 0.23
  2. Ruth J. Muschel · 4 shared papers, 2016–2017 · strength 0.23
  3. Emmanouil Fokas Fokas · 4 shared papers, 2016–2017 · strength 0.23
  4. Angela Diana · 3 shared papers, 2016–2017 · strength 0.17
  5. Keaton Ian Jones · 2 shared papers, 2017 · strength 0.12
  6. Owen James Sansom · 2 shared papers, 2017 · strength 0.12
  7. Lai Mun Wang · 2 shared papers, 2016 · strength 0.11
  8. Eric E. O’Neill · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.